Skip to main content

Table 1 Sample description for assessed MitraClip (MC group; N = 40)

From: Effects of MitraClip on cognitive and psychological function in heart failure patients: the sicker the better

  Pre (t0) Post (t1)
COGBAT norm percentile (≥ 50 = healthy)
 Planning ability (median; IQR) 30 (11.25 to 42.50) 65 (35 to 80)
 Figural memory (median; IQR) 22.5 (0 to 50) 45 (16.25 to 75)
Patient characteristics and biomarkers
 Age (years; median) 73
 Sex (female) 19/40 (47.5%)
 MWT-B intelligence quotient (IQ) 110.83 ± 16.3
 STS-score (%) 5.16 (5.24)
 Psychopharmacological medication (n) 6 (15%)
 Ejection fraction (%) 35 ± 15 35 ± 16
 6 min walk distance test (m) 366 ± 7 415 ± 115
 NT-ProBNP (ng/L) (median) 3880 3627
 hsTnT (pg/mL) 36 ± 33 46 ± 80
Pathogenesis and comorbidity
 ICMP (%) 21/40 (52.5%)
 DCMP (%) 19/40 (47.5%)
 Implantable cardioverter defibrillator (%) 15/40 (37.5%)
 Prior cardiothoracic surgery (%) 9/40 (22.5%)
 Atrial fibrillation (%) 20/40 (50%)
 Prior stroke (%) 4/40 (10%)
 Increased retention values (> 1.3 mg/dL) (%) 11/40 (27.5%)
 Severe sleep apnea syndrome (%) 4/40 (10%)
 Diabetes mellitus (%) 6/40 (15%)
 Pulmonary disease 8/40 (20%)
 Cancer (%) 1/40 (2.5%)
Functional Mitral valve regurgitation (FMR)
 FMR ≤ I° 0 14/40 (35%)
 FMR ≤ II° 0 23/40 (57.5%)
 FMR > II°–< III° 4/40 (10%) 3/40 (7.5%)
 FMR III° 11/40 (27.5%) 0
 FMR IV° 23/40 (57.5%) 0
NYHA functional classification
 NYHA I 0 1/40 (2.5%)
 NYHA II 3/40 (7.5%) 24/40 (60%)
 NYHA III 32/40 (80%) 15/40 (37.5%)
 NYHA IV 5/40 (12.5%) 0
  1. MWT-B multiple selection vocabulary test, STS-score risk score of the Society of Thoracic Surgeons to predict operative mortality of adult cardiac surgery, NT-ProBNP N-terminal pro-brain natriuretic peptide, hsTnT high-sensitive Troponin T, ICMP ischemic cardiomyopathy, DCMP dilated cardiomyopathy, NYHA New York Heart Association, SD standard deviation, IQR interquartile range